Risk for excessive anticoagulation during hemodialysis is associated with type of vascular access and bedside coagulation testing: Results of a cross-sectional study

Risk for excessive anticoagulation during hemodialysis is associated with type of vascular access and bedside coagulation testing: Results of a cross-sectional study

BackgroundRecommendations and practice patterns for heparin dosing during hemodialysis show substantial heterogeneity and are scantly supported by evidence. This study assessed the variability in unfractionated heparin (UFH) dosing during hemodialysis and its clinical and biological anticoagulatory...

Full description

Bibliographic Details
Main Authors: Marijke De Troyer, Karl Martin Wissing, Dieter De Clerck, Marie-Laure Cambier, Tom Robberechts, Annelies Tonnelier, Karlien François
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Medicine
Subjects:
hemodialysis
heparin
dialyzer
anticoagulation
activated partial thromboplastin time
activated clotting time
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1009748/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.1009748/full

Similar Items